Allarity Therapeutics CFO Jeffrey Ervin moves to full-time; gets $367.7K salary, $160K RSUs

Allarity Therapeutics, Inc.

CFO Jeffrey S. Ervin transitioned from part-time to full-time effective December 3, 2025 under new employment agreement.
Annual base salary set at $367,700; eligible for annual bonus up to 30% of base salary.
Granted restricted stock units valued at $160,000, vesting in equal installments over three years.
Severance of six months base salary if terminated without cause, for good reason, or in connection with change of control.

item 5.02item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.